The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
FDA’s Rare Disease Innovation Hub Releases Strategic Agenda: Implications for Stakeholders in 2025
In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...
Hosted on MSN1mon
FDA CDER director Patrizia Cavazzoni announces resignationThe US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her resignation ahead of Donald ...
Further, many biologics are manufactured using biotechnology. CDER promotes and protects the public's health by ensuring that all prescription and nonprescription drugs marketed in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results